DEL FABRO, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 558
AS - Asia 447
EU - Europa 187
SA - Sud America 132
AF - Africa 13
Totale 1.337
Nazione #
US - Stati Uniti d'America 536
SG - Singapore 178
BR - Brasile 110
HK - Hong Kong 97
CN - Cina 58
IT - Italia 55
VN - Vietnam 46
FR - Francia 34
DE - Germania 25
IE - Irlanda 17
GB - Regno Unito 15
CA - Canada 13
IN - India 13
AR - Argentina 9
BD - Bangladesh 9
PL - Polonia 8
TR - Turchia 8
AT - Austria 7
MX - Messico 7
NL - Olanda 6
IQ - Iraq 5
CL - Cile 4
CO - Colombia 4
IL - Israele 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
EG - Egitto 3
ES - Italia 3
FI - Finlandia 3
ID - Indonesia 3
PK - Pakistan 3
RU - Federazione Russa 3
AZ - Azerbaigian 2
EE - Estonia 2
ET - Etiopia 2
JP - Giappone 2
LT - Lituania 2
NP - Nepal 2
SE - Svezia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
EC - Ecuador 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MY - Malesia 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 1.337
Città #
Dallas 225
Hong Kong 97
Singapore 80
San Jose 62
Ashburn 54
The Dalles 35
Chicago 29
Beijing 23
Ho Chi Minh City 22
Florence 20
Dublin 17
Santa Clara 10
São Paulo 9
Assago 8
Frankfurt am Main 8
Rome 7
Düsseldorf 6
Hanoi 6
Milan 6
Istanbul 5
New York 5
San Francisco 5
Baghdad 4
Bexley 4
Brooklyn 4
Hillsboro 4
Los Angeles 4
Manchester 4
Mexico City 4
Orem 4
Warsaw 4
Bogotá 3
Brasília 3
Catania 3
Charlotte 3
Da Nang 3
Jeddah 3
London 3
Mumbai 3
Reston 3
Abbotsford 2
Addis Ababa 2
Atlanta 2
Baku 2
Belo Horizonte 2
Campinas 2
Cape Town 2
Changsha 2
Diadema 2
Fortaleza 2
Haiphong 2
Helsinki 2
Independencia 2
Lauterbourg 2
Lençóis Paulista 2
Montreal 2
Newark 2
Nuremberg 2
Pune 2
Rio de Janeiro 2
São Bernardo do Campo 2
Tashkent 2
Tel Aviv 2
Wroclaw 2
Abu Dhabi 1
Adana 1
Agudos 1
Ahmedabad 1
Albox 1
Alegre 1
Alexandria 1
Alto Araguaia 1
Amsterdam 1
Ananindeua 1
Ankara 1
Anápolis 1
Aquiraz 1
Aracaju 1
Araçatuba 1
As Sālimīyah 1
Bacabal 1
Barcelona 1
Barra Mansa 1
Beirut 1
Belém 1
Bengaluru 1
Berazategui 1
Berlin 1
Betim 1
Bishkek 1
Biên Hòa 1
Bollwiller 1
Bom Jardim de Goiás 1
Boston 1
Bragança 1
Braintree 1
Buenos Aires 1
Buffalo 1
Cabreúva 1
Cachoeirinha 1
Totale 886
Nome #
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 77
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape 65
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia 64
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over 64
Feasibility, tolerability and efficacy of carfilzomib in combination with lenalidomide and dexamethasone in relapsed refractory myeloma patients: A retrospective real-life survey of the sicilian myeloma network 57
Multiple Myeloma in 2023 Ways: From Trials to Real Life 55
Chemotherapy extravasation: diagnosis, prevention and management 52
Serum free light chains and multiple myeloma: Is it time to extend their application? 52
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia 51
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 51
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 50
Emergencies in Hematology: Why, When and How I Treat? 49
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study 48
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 47
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 47
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 46
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 45
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 44
Lenalidomide and pomalidomide improve function and induce fcγri/cd64 in multiple myeloma neutrophils 44
Role of serum free light chain assay in relapsed/refractory multiple myeloma. A real‐life unicentric retrospective study 43
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects 43
Clinical benefit of long-term disease control with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients 40
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 38
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 37
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review 35
Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network 32
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 26
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 20
Diffuse large B-cell lymphoma in the new era: prognostic tools for mapping risk 18
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience 12
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients—A Survey from Two Italian Centers 10
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study 10
Pericytes and mesenchymal stromal cells converge toward pro-tumor phenotypes in the tumor microenvironment 7
Totale 1.379
Categoria #
all - tutte 5.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025445 0 0 0 7 10 95 31 80 41 79 66 36
2025/2026934 71 167 161 105 54 61 84 92 87 52 0 0
Totale 1.379